Development of Exercise Protocol to Improve Hypoxic Tolerance

Dr Vishal Bansal0 个研究点目标入组 51 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. All participants must have quit smoking at least eight weeks before inclusion into the study or are non-smokers.
•2.Participants with a clinical diagnosis of moderate to severe chronic respiratory disease requiring enrollment into pulmonary rehabilitation program for their disease management.
•3. Participants who have completed supervised pulmonary rehabilitation program at least three months earlier and require re-induction into the program for their management.
•4.Participants on long term oxygen therapy, their detailed record of requirement and usage of such therapy shall be maintained.
•5. All patient participants should be compliant to pharmacotherapy for their disease management at least one month prior to induction into the study to eliminate the confounding effect due to improvement imparted by pharmacotherapy.
•6. All participants with anemia shall be given appropriate therapy to raise hemoglobin levels to normal prior to induction in the study.

•1.Patient participants having co-morbidities likely to affect the study parameters like Pulmonary artery hypertension, Obesity hypoventilation, cor pulmonale.
•2.Exercise intolerance due to heart failure, angina pectoris, dyspnea of cardiac origin
•3.Endocrinal disorders such as Diabetes mellitus, thyroid disorder which is likely to cause autonomic dysfunction.
•4.Participants in both the groups having episode of acute infection in the month preceding induction into the study or during the study period and patients requiring course of oral steroids during the course of study shall be excluded from the study.
•5.Physiological, musculoskeletal, neurological or psychological impairment impeding training program.

发起方

Dr Vishal Bansal